Jae Hwan Oh

About

Dr. Jae Hwan Oh is a leading colorectal surgeon whose research has fundamentally advanced the surgical management of rectal cancer. His primary contributions lie in pioneering the comparison of robot-assisted versus laparoscopic surgery, demonstrating through high-impact clinical trials that robotic techniques offer significant advantages in precision and short-term outcomes. His landmark 2017 randomized controlled trial, cited over 335 times, provided critical evidence establishing the feasibility and safety of robotic surgery for rectal cancer, particularly in complex cases involving preoperative chemoradiotherapy. Dr. Oh also led a phase II multi-institutional trial (KROG 11-02) exploring novel preoperative chemoradiotherapy regimens, and his work on optimizing prophylactic antibiotic duration in elective colorectal surgery has helped refine perioperative care standards. With his research directly shaping clinical guidelines and improving patient recovery, Dr. Oh is recognized as a key figure in the global shift toward minimally invasive, robot-assisted colorectal procedures.

Research Focus

Key Achievements

Top Papers

1. 1
   Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer

   335 citations · 2017
2. 2
   Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-Term Outcomes

   62 citations · 2015
3. 3
   Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02)

   25 citations · 2014
4. 4
   A Prospective, Multicenter, Randomized Trial for Duration of the Prophylactic Antibiotics after Elective Colorectal Surgery: 3 Days versus 5 Days

   5 citations · 2010

Key Collaborators

Contact & Links